Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease. [electronic resource]
Producer: 20030930Description: II167-73 p. digitalISSN:- 1524-4539
- 3',5'-Cyclic-GMP Phosphodiesterases -- antagonists & inhibitors
- Administration, Inhalation
- Adolescent
- Blood Pressure -- drug effects
- Cardiac Catheterization
- Child
- Child, Preschool
- Combined Modality Therapy
- Cyclic GMP -- blood
- Cyclic Nucleotide Phosphodiesterases, Type 5
- Heart Defects, Congenital -- drug therapy
- Hemodynamics -- drug effects
- Humans
- Infant
- Infusions, Intravenous
- Nitric Oxide -- administration & dosage
- Phosphodiesterase Inhibitors -- administration & dosage
- Piperazines -- administration & dosage
- Postoperative Period
- Pulmonary Artery -- drug effects
- Pulmonary Circulation -- drug effects
- Purines
- Sildenafil Citrate
- Sulfones
- Vascular Resistance -- drug effects
- Vasodilator Agents -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.